Cardiac Amyloidosis Workup in Patients ≥80 Years Old
In patients aged 80 years or older with suspected cardiac amyloidosis, perform immediate screening with serum and urine protein electrophoresis with immunofixation plus serum free light chains, followed by echocardiography with longitudinal strain, and if monoclonal proteins are absent, proceed directly to Tc-99m-PYP bone scintigraphy to confirm ATTR cardiac amyloidosis. 1, 2
Initial Laboratory Screening
The first critical step is to exclude AL amyloidosis, which requires urgent hematology referral and has the worst prognosis without immediate treatment. This age group commonly has wild-type ATTR (ATTRwt), but concomitant monoclonal gammopathy of undetermined significance occurs frequently in older patients, making this distinction essential 1.
Required Blood and Urine Tests:
- Serum free light chain (sFLC) assay with kappa/lambda ratio
- Serum protein electrophoresis with immunofixation (SPEP with IFE)
- Urine protein electrophoresis with immunofixation (UPEP with IFE)
- Troponin and BNP/NT-proBNP 1
Critical pitfall: SPEP/UPEP alone cannot exclude AL amyloidosis because small amounts of monoclonal protein may not be detectable—immunofixation and sFLC assay are both mandatory 1, 3. The sensitivity of this combined approach for detecting AL amyloidosis is 98-100% 4.
Cardiac Imaging
Echocardiography (First-Line)
Perform echocardiography with speckle-tracking longitudinal strain measurement looking for:
- LV wall thickness >1.2 cm (typically symmetrical)
- Reduced global longitudinal strain with apical sparing (base-to-apex gradient)—this is relatively specific for cardiac amyloidosis
- Diastolic dysfunction
- Small pericardial effusion
- Bivalvular thickening 1
Advanced Imaging Based on Monoclonal Protein Results:
If monoclonal proteins are ABSENT:
- Proceed directly to Tc-99m-PYP (or DPD/HMDP) bone scintigraphy 2
- A Perugini score of 2 or 3 with heart-to-contralateral chest ratio ≥1.5 confirms ATTR cardiac amyloidosis without need for biopsy 1, 2
- This noninvasive diagnosis is particularly valuable in octogenarians who may not tolerate endomyocardial biopsy
If monoclonal proteins are PRESENT:
- Urgent hematology referral is mandatory
- Tissue biopsy is required (endomyocardial biopsy, fat pad, bone marrow, or affected organ) with Congo red staining
- Mass spectrometry (LC-MS/MS) is the gold standard for typing the amyloid protein (sensitivity 88%, specificity 96%) 3
- Bone scintigraphy should NOT be performed as it cannot reliably differentiate AL from ATTR when monoclonal proteins are present 2
CMR (Alternative or Complementary)
If available and patient can tolerate it, cardiac MRI provides:
- Late gadolinium enhancement (LGE) in diffuse transmural or subendocardial pattern
- Elevated native T1 mapping
- Increased extracellular volume expansion 1
However, CMR cannot reliably differentiate AL from ATTR subtypes 1.
Genetic Testing
Once ATTR cardiac amyloidosis is confirmed (by positive bone scintigraphy without monoclonal proteins), TTR gene sequencing is mandatory to differentiate:
- Hereditary ATTR (ATTRv) - requires genetic counseling and family screening
- Wild-type ATTR (ATTRwt) - most common in this age group 2, 1
Age-Specific Considerations
In patients ≥80 years old:
- ATTRwt is the most likely diagnosis, particularly in men, though increasingly recognized in women 1
- The noninvasive diagnostic pathway (monoclonal protein screen → bone scintigraphy → genetic testing) is preferred to avoid biopsy risks 2
- Concomitant MGUS is common but does not exclude ATTR; tissue typing by mass spectrometry is essential if biopsy is performed 1
- Consider frailty assessment as it impacts treatment decisions and prognosis 5
Diagnostic Algorithm Summary
- 12-lead ECG (look for low voltage despite wall thickness) 1
- Troponin and BNP/NT-proBNP 1
- Complete monoclonal protein screen (sFLC + SPEP/IFE + UPEP/IFE) 1, 2
- Echocardiography with strain imaging 1
- If no monoclonal protein: Tc-99m-PYP scintigraphy → if positive (grade 2-3), diagnosis confirmed
- If monoclonal protein present: Hematology referral + tissue biopsy with mass spectrometry
- Once ATTR confirmed: TTR genetic testing 2
The key advantage of this algorithm in octogenarians is that ATTR cardiac amyloidosis can be diagnosed entirely noninvasively if monoclonal proteins are absent and bone scintigraphy is positive, avoiding the risks of endomyocardial biopsy in this vulnerable population 2, 1.